Physician Assistant · Garland, TX
NPI
1659636488
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1015 W Centerville Rd
Garland, TX, 75041
Phone (678) 283-7427
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,935 services
Medicare patients, 2024
407
Average age 74
Drug cost, 2024
$324K
859 prescriptions
Company payments, 2025
$2,314
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason Tharpe was code 17003 (destruction skin lesion), 417 times for 87 patients. In total Jason Tharpe billed 1,935 services in 58 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 417 | 87 | $4.21 | $1,756 |
| 99214 Office E&M - Established | Office | 383 | 238 | $74.37 | $28K |
| 17110 Destruction Skin Lesion | Office | 200 | 142 | $61.44 | $12K |
| 99213 Office E&M - Established | Office | 188 | 152 | $53.13 | $9,988 |
| 17000 Destruction Skin Lesion | Office | 180 | 130 | $28.13 | $5,064 |
| 99204 Office E&M - New | Office | 82 | 82 | $90.71 | $7,438 |
| 11311 Removal or Shaving of Skin Growth | Office | 57 | 48 | $68.75 | $3,919 |
| 11301 Removal or Shaving of Skin Growth | Office | 47 | 39 | $53.31 | $2,505 |
| 99203 Office E&M - New | Office | 45 | 45 | $54.50 | $2,453 |
| 11306 Removal or Shaving of Skin Growth | Office | 40 | 31 | $60.10 | $2,404 |
| 11102 Skin Biopsy | Office | 40 | 38 | $48.26 | $1,930 |
| 11310 Removal or Shaving of Skin Growth | Office | 32 | 30 | $58.98 | $1,887 |
| 11312 Removal or Shaving of Skin Growth | Office | 28 | 24 | $88.68 | $2,483 |
| 11302 Removal or Shaving of Skin Growth | Office | 24 | 20 | $68.20 | $1,637 |
| 10060 Skin | Office | 20 | 19 | $70.69 | $1,414 |
By year: 2022 $49K for 992 services; 2023 $77K for 1,356 services; 2024 $99K for 1,935 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jason Tharpe prescribed most often to Medicare patients was Clobetasol Propionate, with 204 prescriptions and refills. In total Jason Tharpe wrote 859 Medicare prescriptions that cost $324K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 204 | 216 | 144 | $7,006 |
| Triamcinolone Acetonide Generic | 83 | 113 | 67 | $1,085 |
| Mupirocin Generic | 61 | 61 | 49 | $516 |
| Ketoconazole Generic | 60 | 74 | 37 | $979 |
| Doxycycline Hyclate Generic | 45 | 57 | 24 | $1,059 |
| Clindamycin Phosphate Generic | 45 | 47 | 35 | $1,737 |
| Prednisone Generic | 35 | 35 | 33 | $97.76 |
| Imiquimod Generic | 27 | 35 | 16 | $848 |
| Desonide Generic | 25 | 25 | 21 | $1,357 |
| Klisyri Tirbanibulin | 24 | 24 | 19 | $29K |
| Econazole Nitrate Generic | 23 | 23 | 15 | $1,183 |
| Hydrocortisone Generic | 22 | 22 | 20 | $208 |
| Valacyclovir Valacyclovir Hcl | 19 | 27 | Under 11 | $326 |
| Cephalexin Generic | 13 | 15 | 11 | $101 |
| Otezla Apremilast | 12 | 12 | Under 11 | $62K |
Brand drugs: 83 claims; generic drugs: 776 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason Tharpe $2,314 ($2,314 in general payments such as food, travel and fees) from 20 companies. The largest payer was Genzyme Corporation with $469.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 11 | $469 |
| Galderma Laboratories, L.P. GALD.SW | 28 | $339 |
| LEO Pharma Inc. | 9 | $247 |
| Almirall LLC | 7 | $171 |
| Pfizer Inc. PFE | 14 | $156 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $153 |
| Incyte Corporation INCY | 7 | $137 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $134 |
| Arcutis Biotherapeutics, Inc. ARQT | 6 | $115 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $72.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.